PlainRecalls
FDA Drug Moderate Class II Terminated

hydrALAZINE HCl Tablets, USP, 10 mg, 100 Tablets per carton (10x10 blister packs), Rx only, Distributed by: MAJOR PHARMACEUTICALS, Livonia, MI 48152 USA. NDC # 0904-6440-61

Reported: March 23, 2022 Initiated: February 24, 2022 #D-0653-2022

Product Description

hydrALAZINE HCl Tablets, USP, 10 mg, 100 Tablets per carton (10x10 blister packs), Rx only, Distributed by: MAJOR PHARMACEUTICALS, Livonia, MI 48152 USA. NDC # 0904-6440-61

Reason for Recall

Failed Impurities/Degradation Specifications: Out of specification result obtained during routine stability testing for Impurities.

Details

Recalling Firm
The Harvard Drug Group
Units Affected
5,953 cartons
Distribution
Nationwide within USA
Location
Livonia, MI

Frequently Asked Questions

What product was recalled?
hydrALAZINE HCl Tablets, USP, 10 mg, 100 Tablets per carton (10x10 blister packs), Rx only, Distributed by: MAJOR PHARMACEUTICALS, Livonia, MI 48152 USA. NDC # 0904-6440-61. Recalled by The Harvard Drug Group. Units affected: 5,953 cartons.
Why was this product recalled?
Failed Impurities/Degradation Specifications: Out of specification result obtained during routine stability testing for Impurities.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 23, 2022. Severity: Moderate. Recall number: D-0653-2022.